Busting the billion-dollar myth: how to slash the cost of drug development

When the population in need of a new dug is very poor, the private sector has little incentive to create and test new drugs. Through product development partnership, the Drugs for Neglected Diseases initiative keeps the costs of drug development down. For example, the non-profit pays for and runs clinical trials under the name of the drug company, helping their image, in return the drug company doesn’t patent the drug and sells it to the people in need for a much a cheaper price.

Related Stories